Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury
Abstract Background Bone marrow mesenchymal stem cells (BMSCs) and their secreted exosomes have been shown to possess therapeutic potential in various diseases, including diabetic retinopathy (DR). Retinal microvascular endothelial cell (RMEC) injury is a key factor in DR, and understanding the unde...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-025-01804-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849685901741916160 |
|---|---|
| author | Chao Niu Daoquan Dong Longjiang Cui Yingli Dong Wei Wang |
| author_facet | Chao Niu Daoquan Dong Longjiang Cui Yingli Dong Wei Wang |
| author_sort | Chao Niu |
| collection | DOAJ |
| description | Abstract Background Bone marrow mesenchymal stem cells (BMSCs) and their secreted exosomes have been shown to possess therapeutic potential in various diseases, including diabetic retinopathy (DR). Retinal microvascular endothelial cell (RMEC) injury is a key factor in DR, and understanding the underlying molecular mechanisms is crucial for the treatment of DR. The study investigated the role of MSC-derived exosomes in RMEC injury and the underlying mechanism. Methods Human retinal microvascular endothelial cells (HRMECs) were exposed to high glucose (HG) to establish an in vitro DR model. Exosomes were isolated from BMSCs using differential centrifugation and co-incubated with HRMECs for functional studies. mRNA expression of ataxin 2 like (ATXN2L), methyltransferase-like 3 (METTL3), and forkhead box L1 (FOXL1) was assessed by quantitative real-time polymerase chain reaction. Protein expression was evaluated by western blotting. Cell viability was measured with a cell counting kit-8 assay, and pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) were analyzed by enzyme-linked immunosorbent assays. Apoptosis was analyzed through flow cytometry. MDA levels, GSH-Px activity, and ROS levels were determined by colorimetric methods and fluorescence microscopy, respectively. The association of METTL3 with ATXN2L and FOXL1 was investigated using a dual-luciferase reporter assay and RNA immunoprecipitation assay. Results HG treatment increased the secretion of pro-inflammatory factors, apoptosis rate, and oxidative stress in HRMECs. BMSC-derived exosomes inhibited inflammation, apoptosis and oxidative stress in HRMECs by transferring FOXL1 into HRMECs. FOXL1 functioned as an RNA-binding protein of METTL3, which stabilized ATXN2L mRNA expression through m6A methylation in HRMECs. ATXN2L expression was reduced in DR patients’ serum and HG-treated HRMECs. Overexpression of ATXN2L mitigated the high glucose-induced inflammation, apoptosis, and oxidative stress in HRMECs. Conclusion Exosomal FOXL1 from BMSCs stabilized METTL3 to increase ATXN2L expression, thus offering a protective effect against high glucose-induced injury in HRMECs. This finding holds clinical significance for the development of targeted therapies for DR. |
| format | Article |
| id | doaj-art-d2d221322bdb45d7be8133d033f6d872 |
| institution | DOAJ |
| issn | 1758-5996 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BMC |
| record_format | Article |
| series | Diabetology & Metabolic Syndrome |
| spelling | doaj-art-d2d221322bdb45d7be8133d033f6d8722025-08-20T03:22:54ZengBMCDiabetology & Metabolic Syndrome1758-59962025-06-0117111310.1186/s13098-025-01804-7Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injuryChao Niu0Daoquan Dong1Longjiang Cui2Yingli Dong3Wei Wang4Department of Ophthalmology, Henan Provincial People’s HospitalDepartment of Ophthalmology, Henan Provincial People’s HospitalDepartment of Ophthalmology, Henan Provincial People’s HospitalDepartment of Ophthalmology, Henan Provincial People’s HospitalDepartment of Oncology, Henan Provincial People’s HospitalAbstract Background Bone marrow mesenchymal stem cells (BMSCs) and their secreted exosomes have been shown to possess therapeutic potential in various diseases, including diabetic retinopathy (DR). Retinal microvascular endothelial cell (RMEC) injury is a key factor in DR, and understanding the underlying molecular mechanisms is crucial for the treatment of DR. The study investigated the role of MSC-derived exosomes in RMEC injury and the underlying mechanism. Methods Human retinal microvascular endothelial cells (HRMECs) were exposed to high glucose (HG) to establish an in vitro DR model. Exosomes were isolated from BMSCs using differential centrifugation and co-incubated with HRMECs for functional studies. mRNA expression of ataxin 2 like (ATXN2L), methyltransferase-like 3 (METTL3), and forkhead box L1 (FOXL1) was assessed by quantitative real-time polymerase chain reaction. Protein expression was evaluated by western blotting. Cell viability was measured with a cell counting kit-8 assay, and pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) were analyzed by enzyme-linked immunosorbent assays. Apoptosis was analyzed through flow cytometry. MDA levels, GSH-Px activity, and ROS levels were determined by colorimetric methods and fluorescence microscopy, respectively. The association of METTL3 with ATXN2L and FOXL1 was investigated using a dual-luciferase reporter assay and RNA immunoprecipitation assay. Results HG treatment increased the secretion of pro-inflammatory factors, apoptosis rate, and oxidative stress in HRMECs. BMSC-derived exosomes inhibited inflammation, apoptosis and oxidative stress in HRMECs by transferring FOXL1 into HRMECs. FOXL1 functioned as an RNA-binding protein of METTL3, which stabilized ATXN2L mRNA expression through m6A methylation in HRMECs. ATXN2L expression was reduced in DR patients’ serum and HG-treated HRMECs. Overexpression of ATXN2L mitigated the high glucose-induced inflammation, apoptosis, and oxidative stress in HRMECs. Conclusion Exosomal FOXL1 from BMSCs stabilized METTL3 to increase ATXN2L expression, thus offering a protective effect against high glucose-induced injury in HRMECs. This finding holds clinical significance for the development of targeted therapies for DR.https://doi.org/10.1186/s13098-025-01804-7Diabetic retinopathyMesenchymal stem cellsExosomesFOXL1METTL3ATXN2L |
| spellingShingle | Chao Niu Daoquan Dong Longjiang Cui Yingli Dong Wei Wang Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury Diabetology & Metabolic Syndrome Diabetic retinopathy Mesenchymal stem cells Exosomes FOXL1 METTL3 ATXN2L |
| title | Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury |
| title_full | Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury |
| title_fullStr | Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury |
| title_full_unstemmed | Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury |
| title_short | Exosomal FOXL1 from bone marrow mesenchymal stem cells activates the METTL3/ATXN2L pathway to ameliorate high glucose-induced human retinal microvascular endothelial cell injury |
| title_sort | exosomal foxl1 from bone marrow mesenchymal stem cells activates the mettl3 atxn2l pathway to ameliorate high glucose induced human retinal microvascular endothelial cell injury |
| topic | Diabetic retinopathy Mesenchymal stem cells Exosomes FOXL1 METTL3 ATXN2L |
| url | https://doi.org/10.1186/s13098-025-01804-7 |
| work_keys_str_mv | AT chaoniu exosomalfoxl1frombonemarrowmesenchymalstemcellsactivatesthemettl3atxn2lpathwaytoamelioratehighglucoseinducedhumanretinalmicrovascularendothelialcellinjury AT daoquandong exosomalfoxl1frombonemarrowmesenchymalstemcellsactivatesthemettl3atxn2lpathwaytoamelioratehighglucoseinducedhumanretinalmicrovascularendothelialcellinjury AT longjiangcui exosomalfoxl1frombonemarrowmesenchymalstemcellsactivatesthemettl3atxn2lpathwaytoamelioratehighglucoseinducedhumanretinalmicrovascularendothelialcellinjury AT yinglidong exosomalfoxl1frombonemarrowmesenchymalstemcellsactivatesthemettl3atxn2lpathwaytoamelioratehighglucoseinducedhumanretinalmicrovascularendothelialcellinjury AT weiwang exosomalfoxl1frombonemarrowmesenchymalstemcellsactivatesthemettl3atxn2lpathwaytoamelioratehighglucoseinducedhumanretinalmicrovascularendothelialcellinjury |